GSK hails breakthrough bird flu vaccine
GlaxoSmithKline (GSK) said it has developed a vaccine against the H5N1 bird flu strain that can trigger an immune response at a much lower dose than other vaccines in development.
Archives for July 30, 2006
Murex licenses Ariadne's drug R&D software solution
Murex Pharmaceuticals has licensed Ariadne's software solution, which is to play a vital role in the visualisation and analysis of biological pathways and gene regulation networks for cancer therapeutics development.
Striking the right drug delivery partnership
Partnerships in drug delivery need to fairly reflect the risk all parties take but there must also be a champion to drive the project forward, according to Pfizer's director of drug delivery.
First steps forward in electronic ordering of controlled substances
Purdue Pharma is the first drug manufacturer to implement a new software program that allows firms to order all Schedule I & II controlled substance purchases on a single electronic form - potentially saving up to 90 per cent on ordering costs.
Research focuses on Parkinson's disease genetic model
Researchers have taken a special interest in mechanisms they have identified as an explanation for the causes of Parkinson's disease, which they say, may facilitate research aimed at finding novel medical treatments and other therapies.
New report re-emphasises clinical trial safety
A new report compiled in the wake of the drug trial scandal, which left six men fighting for their lives, has re-iterated the call for scientists to proceed with extreme caution when testing such drugs in the future.
Clued-up diabetics driving European diabetes market growth
The insulin market is set to explode over the next five years as uptake of insulin therapy is likely to increase with sufferers benefiting from heightened awareness and knowledge as well as the influx of affordable, innovative product solutions.